CD33 and hematologic disorder: Therefore, CAR-T cells are maintained in a less differentiated state, as demonstrated in CD33- (142), CD5- (143), CD19- (144, 145) and Minor histocompatibility antigen (MiHA)- (146) CAR-T cells against various hematological malignancies.